{
    "ticker": "PMVP",
    "info": {
        "address1": "1 Research Way",
        "city": "Princeton",
        "state": "NJ",
        "zip": "08540",
        "country": "United States",
        "phone": "609 642 6670",
        "website": "https://www.pmvpharma.com",
        "industry": "Biotechnology",
        "industryKey": "biotechnology",
        "industryDisp": "Biotechnology",
        "sector": "Healthcare",
        "sectorKey": "healthcare",
        "sectorDisp": "Healthcare",
        "longBusinessSummary": "PMV Pharmaceuticals, Inc., a precision oncology company, engages in the discovery and development of small molecule and tumor-agnostic therapies for p53 mutations in cancer. It's lead product candidate is PC14586, a small molecule that corrects mutant p53 protein containing the Y220C mutation and restores wild-type p53 function. The company was formerly known as PJ Pharmaceuticals, Inc. and changed its name to PMV Pharmaceuticals, Inc. in July 2013. PMV Pharmaceuticals, Inc. was incorporated in 2013 and is based in Princeton, New Jersey.",
        "fullTimeEmployees": 63,
        "companyOfficers": [
            {
                "maxAge": 1,
                "name": "Dr. David H. Mack Ph.D.",
                "age": 61,
                "title": "Co-Founder, CEO, President & Director",
                "yearBorn": 1962,
                "fiscalYear": 2023,
                "totalPay": 881083,
                "exercisedValue": 0,
                "unexercisedValue": 732137
            },
            {
                "maxAge": 1,
                "name": "Dr. Arnold J. Levine Ph.D.",
                "age": 83,
                "title": "Co-Founder, Director & Member of Scientific Advisory Board",
                "yearBorn": 1940,
                "fiscalYear": 2023,
                "totalPay": 140000,
                "exercisedValue": 0,
                "unexercisedValue": 0
            },
            {
                "maxAge": 1,
                "name": "Dr. Deepika  Jalota Pharm.D.",
                "age": 46,
                "title": "Chief Development Officer",
                "yearBorn": 1977,
                "fiscalYear": 2023,
                "totalPay": 593898,
                "exercisedValue": 0,
                "unexercisedValue": 0
            },
            {
                "maxAge": 1,
                "name": "Mr. Michael  Carulli",
                "age": 49,
                "title": "Chief Financial Officer",
                "yearBorn": 1974,
                "fiscalYear": 2023,
                "exercisedValue": 0,
                "unexercisedValue": 0
            },
            {
                "maxAge": 1,
                "name": "Mr. Robert  Ticktin",
                "age": 61,
                "title": "General Counsel, Head of Operations & Company Secretary",
                "yearBorn": 1962,
                "fiscalYear": 2023,
                "exercisedValue": 0,
                "unexercisedValue": 0
            },
            {
                "maxAge": 1,
                "name": "Mr. Tim  Smith",
                "title": "Senior VP and Head of Corporate Development & Investor Relations",
                "fiscalYear": 2023,
                "exercisedValue": 0,
                "unexercisedValue": 0
            },
            {
                "maxAge": 1,
                "name": "Ms. Crystal  Zuckerman",
                "title": "Vice President of Human Resources",
                "fiscalYear": 2023,
                "exercisedValue": 0,
                "unexercisedValue": 0
            },
            {
                "maxAge": 1,
                "name": "Dr. Binh  Vu Ph.D.",
                "title": "Senior Vice President of Drug Discovery & CMC",
                "fiscalYear": 2023,
                "exercisedValue": 0,
                "unexercisedValue": 0
            },
            {
                "maxAge": 1,
                "name": "Dr. Marc  Fellous M.D.",
                "title": "Senior VP and Head of Clinical Development & Medical Affairs",
                "fiscalYear": 2023,
                "exercisedValue": 0,
                "unexercisedValue": 0
            },
            {
                "maxAge": 1,
                "name": "Ms. Laura  De Leon",
                "title": "VP & Head of Clinical Operations",
                "fiscalYear": 2023,
                "exercisedValue": 0,
                "unexercisedValue": 0
            }
        ],
        "auditRisk": 6,
        "boardRisk": 6,
        "compensationRisk": 8,
        "shareHolderRightsRisk": 7,
        "overallRisk": 7,
        "governanceEpochDate": 1730073600,
        "compensationAsOfEpochDate": 1703980800,
        "maxAge": 86400,
        "priceHint": 4,
        "previousClose": 1.65,
        "open": 1.66,
        "dayLow": 1.59,
        "dayHigh": 1.66,
        "regularMarketPreviousClose": 1.65,
        "regularMarketOpen": 1.66,
        "regularMarketDayLow": 1.59,
        "regularMarketDayHigh": 1.66,
        "beta": 1.516,
        "forwardPE": -1.0127388,
        "volume": 312379,
        "regularMarketVolume": 312379,
        "averageVolume": 208892,
        "averageVolume10days": 194510,
        "averageDailyVolume10Day": 194510,
        "bid": 1.56,
        "ask": 1.63,
        "bidSize": 100,
        "askSize": 100,
        "marketCap": 84492440,
        "fiftyTwoWeekLow": 1.4,
        "fiftyTwoWeekHigh": 3.47,
        "fiftyDayAverage": 1.5422,
        "twoHundredDayAverage": 1.674925,
        "currency": "USD",
        "enterpriseValue": -118012592,
        "floatShares": 38421885,
        "sharesOutstanding": 51519800,
        "sharesShort": 975907,
        "sharesShortPriorMonth": 1057979,
        "sharesShortPreviousMonthDate": 1726185600,
        "dateShortInterest": 1728950400,
        "sharesPercentSharesOut": 0.0189,
        "heldPercentInsiders": 0.02311,
        "heldPercentInstitutions": 0.84403,
        "shortRatio": 4.9,
        "shortPercentOfFloat": 0.0222,
        "impliedSharesOutstanding": 53139900,
        "bookValue": 4.16,
        "priceToBook": 0.38221157,
        "lastFiscalYearEnd": 1703980800,
        "nextFiscalYearEnd": 1735603200,
        "mostRecentQuarter": 1719705600,
        "netIncomeToCommon": -48879000,
        "trailingEps": -0.93,
        "forwardEps": -1.57,
        "pegRatio": -0.07,
        "enterpriseToEbitda": 1.577,
        "52WeekChange": -0.16666669,
        "SandP52WeekChange": 0.3763833,
        "exchange": "NMS",
        "quoteType": "EQUITY",
        "symbol": "PMVP",
        "underlyingSymbol": "PMVP",
        "shortName": "PMV Pharmaceuticals, Inc.",
        "longName": "PMV Pharmaceuticals, Inc.",
        "firstTradeDateEpochUtc": 1601040600,
        "timeZoneFullName": "America/New_York",
        "timeZoneShortName": "EDT",
        "uuid": "acf047b4-1d7b-3474-ba6c-19bf6787a0f7",
        "messageBoardId": "finmb_259910295",
        "gmtOffSetMilliseconds": -14400000,
        "currentPrice": 1.59,
        "targetHighPrice": 18.0,
        "targetLowPrice": 5.0,
        "targetMeanPrice": 8.2,
        "targetMedianPrice": 6.0,
        "recommendationMean": 1.8,
        "recommendationKey": "buy",
        "numberOfAnalystOpinions": 5,
        "totalCash": 212919008,
        "totalCashPerShare": 4.133,
        "ebitda": -74840000,
        "totalDebt": 12990000,
        "quickRatio": 18.702,
        "currentRatio": 19.217,
        "debtToEquity": 6.061,
        "returnOnAssets": -0.19878,
        "returnOnEquity": -0.22623,
        "freeCashflow": -39141876,
        "operatingCashflow": -45526000,
        "financialCurrency": "USD",
        "trailingPegRatio": null
    }
}